MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice
Milacemide was found to protect Swiss albino CD1 mice but not Sprague Dawley rats against bicuculline-induced lethality. Since it had been previously suggested that the anticonvulsant activity of milacemide might be related to MAO-B- mediated glycine formation, brain and liver MAO-A and-B activities and the urinary metabolic pattern of milacemide were determined in the same mice and rat strains. Similar brain and liver MAO activities were found in the two species, except for liver MAO-A activity which was higher in rats. After the same oral dose of milacemide, the percent of the dose excreted as glycinamide was significantly higher in mice than in rats, whereas that excreted as metabolite UK1 was significantly higher in rats. These results support the hypothesis of a glycine-mediated anticonvulsant activity for milacemide and suggest that the increased formation of UK1 to the detriment of glycinamide might account for the lack of protection against bicuculline-induced lethality by milacemide in rats.
KeywordsAnticonvulsant Activity Synaptosomal Fraction Tonic Convulsion Final Specific Activity Brain Monoamine Oxidase
Unable to display preview. Download preview PDF.
- Cao Danh H, Strolin Benedetti M, Dostert P (1984) Differential changes in monoamine oxidase A and B activity in aging rat tissues. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors. Academic Press, London, pp 301–317.Google Scholar
- Chambon JP, Hallot A, Bizière K (1986) CM 40907 and SR41378: two piperidino-pyridazine derivatives. Curr Probl Epilepsy 4:313–316.Google Scholar
- Christophe J, Kutzner R, Nguyen-Bui ND, Damien C, Chatelain P, Gillet L (1983) Conversion of orally administered 2-n. pentylaminoacetamide into glycinamide and glycine in the rat brain. Life Sci 33:533–541.Google Scholar
- Frey H-H, Löscher W (1976) Di-n-propylacetic acid — Profile of anticonvulsant activity in mice. Arzneim-Forsch 26:299–301.Google Scholar
- Meldrum BS, Kehr W, Stephens DN, Bhargava AS (1986) ZK 91296 and ZK 93423: β-carbolines with partial or full agonist activity at benzodiazepine receptors. Curr Probl Epilepsy 4:303–308.Google Scholar
- Roncucci R, Gillet C, Cordi A, Martens M, Roba J, Niebes P, Lambelin G, van Dorsser W (1980) Glycinamide derivatives and their use. Ger Offen 3,010,599.Google Scholar